Schonfeld Strategic Advisors LLC Global Blood Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $572,507 - $959,913	-25,673 Reduced 61.75%	15,906 $508,000
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $1.33 Million - $1.85 Million	-51,961 Reduced 55.55%	41,579 $1.44 Million
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $1.07 Million - $1.73 Million	43,067 Added 85.33%	93,540 $2.74 Million
Q3 2021 Nov 16, 2021	BUY	$25.48 - $37.34 $789,192 - $1.16 Million	30,973 Added 158.84%	50,473 $1.29 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $632,970 - $846,690	19,500 New	19,500 $683,000
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $1.86 Million - $2.43 Million	-47,739 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $1.8 Million - $3.04 Million	47,739 New	47,739 $2.07 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $5.84 Million - $7.45 Million	-128,700 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $2.93 Million - $3.53 Million	55,700 Added 76.3%	128,700 $6.77 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $2.92 Million - $3.9 Million	73,000 New	73,000 $3.86 Million
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $359,556 - $532,038	-11,400 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $2.51 Million - $3.38 Million	-66,100 Reduced 85.29%	11,400 $433,000
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $3 Million - $3.89 Million	77,500 New	77,500 $3.5 Million
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $885,060 - $1.47 Million	-22,350 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $1.5 Million - $2.31 Million	-50,541 Reduced 69.34%	22,350 $880,000
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $1.83 Million - $2.26 Million	72,891	72,891 $2.26 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account